[Chemotherapy of the non-small cell bronchogenic carcinoma]
- PMID: 6189039
- DOI: 10.1159/000215188
[Chemotherapy of the non-small cell bronchogenic carcinoma]
Abstract
From 1976 to 1981 61 patients (50 men and 11 women) with non-small cell bronchogenic carcinoma (i.e. squamous cell or adeno-carcinoma) received a chemotherapy treatment based on two cytostatic drug combinations for each histological group. The drugs which were used were cyclophosphamide, adriamycin, vincristine, methotrexate, bleomycin, 5-fluorouracil and procarbazine. All patients had advanced disease and 6 of them had had previous surgical excision of the primary tumor. A large proportion of the patients had received irradiation to the primary site prior to chemotherapy. 1 patient developed a complete remission, 5 developed a partial remission and 34 showed stabilization of their disease. In 21 patients the disease progressed in spite of the treatment. Responders had a significantly longer survival than non-responding patients.
Similar articles
-
Bleomycin, cisplatin, vincristine, and methotrexate in advanced non-small cell bronchogenic carcinoma.Cancer Treat Rep. 1982 Jan;66(1):205-6. Cancer Treat Rep. 1982. PMID: 6171350 No abstract available.
-
[Antineoplastic chemotherapy for bronchial carcinoma].Arch Geschwulstforsch. 1985;55(1):63-71. Arch Geschwulstforsch. 1985. PMID: 2985017 German.
-
Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).JAMA. 1978 Dec 15;240(25):2743-6. JAMA. 1978. PMID: 713008
-
Management of small cell cancer: intensive chemotherapy.Recent Results Cancer Res. 1984;92:58-64. doi: 10.1007/978-3-642-82218-6_5. Recent Results Cancer Res. 1984. PMID: 6330811 Review. No abstract available.
-
[Chemotherapy of lung cancer].Sov Med. 1984;(11):55-61. Sov Med. 1984. PMID: 6084308 Review. Russian. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical